Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers

International Journal of Cancer

Volumn 118, Issue 10, 2006, Pages 2509-2513

  Jung, Barbara ^a,b   Smith, E Julieta ^c   Doctolero, Ryan T ^c   Gervaz, Pascal ^d   Alonso, Julio C ^a   Miyai, Katsumi ^e   Keku, Temitope ^f   Sandler, Robert S ^f   Carethers, John M ^a,b,c,g  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Activin; BAX; DNA mismatch repair; Microsatellite instability; Transforming growth factor

Indexed keywords

PROTEIN BAX; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; BAX GENE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MULTIGENE FAMILY; MUTANT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; TGFBR2 GENE; TUMOR VOLUME;

ACTIVIN RECEPTORS, TYPE II; BCL-2-ASSOCIATED X PROTEIN; COHORT STUDIES; COLONIC NEOPLASMS; FRAMESHIFT MUTATION; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; NEOPLASM STAGING; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SURVIVAL ANALYSIS;

EID: 33646391241     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21710     Document Type: Article

References (24)

1. Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J, Markowitz S. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998;58:3101-4.
2. Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB, III, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196-206.
3. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colon cancer. Cancer Res 1995;55:5548-50.
4. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci USA 2000;97:10872-7.
5. Yagi OK, Akiyama Y, Nomizu T, Iwama T, Endo M, Yuasa Y. Pro-apoptotic gene BAX is frequently mutated in hereditary nonpolyposis colon cancers but not in adenomas. Gastroenterology 1998;114:268-74.
6. Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ, Stine OC. Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 2001;61:6046-9.
7. Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 2004;126:654-9.
8. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989-92.
9. Choi SW, Lee KJ, Bae YA, Min KO, Kwon MS, Kim KM, Rhyu MG. Genetic classification of colon cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002;8:2311-22.
10. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S. Tumor microsatellite instability and clinical outcome in young patients with colon cancer. N Engl J Med 2000;342:69-77.
11. Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colon cancer. Gastroenterology 2004;126:394-401.
12. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-57.
13. Carethers JM, Boland CR. Neoplasia of the gastrointestinal tract. In: Yamada T, Alpers DH, Kaplowitz N, Laine L, Owyang C, Powell DW, eds. Textbook of gastroenterology, 4th ed. Philadelphia, PA: Lippincott-Raven, 2003. 557-83.
14. Carethers JM, Hawn MT, Greenson JK, Hitchcock CL Boland CR. Prognostic significance of allelic lost at chromosome 18q21 for stage II colon cancer. Gastroenterology 1998;114:1188-95.
15. Gervaz P, Cerottini JP, Bouzourene H, Hahnloser D, Doan CL, Benhattar J, Chaubert P, Secic M, Gillet M, Carethers JM. Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colon cancer. Surgery 2002;131:190-7.
16. Satia JA, Keku T, Galanko JA, Martin C, Doctolero RT, Tajima A, Sandier RS, Carethers JM. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2005;14:429-43.
17. Morson BC, Dawson IP, Day DW, Jass JR, Price AB, Williams GT. Malignant epithelial tumors. In: Morson BC, Dawson IP, eds. Gastrointestinal pathology, 3rd ed. Oxford, England: Blackwell Scientific, 1990.608-10.
18. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colon cancer. Cancer Res 1998;58:5248-57.
19. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
20. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, Yoshimura K, Bekku S. Risk factors for an adverse outcome in early invasive colon carcinoma. Gastroenterology 2004;127:385-94.
21. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colon carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;89:328-36.
22. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
23. Samowitz WS, Curtin K, Neuhausen S, Schaffer D, Slattery ML. Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability. Genes Chromosomes Cancer 2002;35:368-71.
24. Woerner SM, Kloor M, Mueller A, Rueschoff J, Friedrichs N, Buettner R, Buzello M, Kienle P, Knaebel H-P, Kunstmann E, Pagenstecher C, Schackert HK, et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005;24:2525-35.